Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018
Mon, December 10, 2018
Fri, December 7, 2018
Thu, December 6, 2018
Wed, December 5, 2018
Tue, December 4, 2018
Mon, December 3, 2018
Fri, November 30, 2018
Thu, November 29, 2018
Wed, November 28, 2018
Tue, November 27, 2018
Mon, November 26, 2018
Fri, November 23, 2018
Wed, November 21, 2018
Tue, November 20, 2018
Mon, November 19, 2018
Fri, November 16, 2018
Thu, November 15, 2018
Wed, November 14, 2018

Isaac Ro Upgraded (ABT) to Strong Buy and Increased Target to $81 on, Nov 30th, 2018


//stocks-investing.news-articles.net/content/201 .. and-increased-target-to-81-on-nov-30th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Isaac Ro of Goldman Sachs, Upgraded "Abbott Laboratories" (ABT) to Strong Buy and Increased Target from $78 to $81 on, Nov 30th, 2018.

Isaac has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 0 agree with Isaac's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Isaac


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $79 on, Thursday, October 18th, 2018
  • Matthew Taylor of "Barclays" Initiated at Buy and Held Target at $80 on, Tuesday, October 16th, 2018
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $80 on, Thursday, October 11th, 2018
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Monday, October 8th, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $80 on, Monday, September 24th, 2018

Publication Contributing Sources